$HLI

Houlihan Lokey, Inc. Stock 12‑Month Price Target Cut to $152.62, Implies 22% Upside

Houlihan Lokey's average stock price target was reduced by analysts from $154.12 to $152.62, with a range of $147 to $165. This implies a 22% upside from the Oct. 7 closing price. The consensus rating remains 'Buy' among 11 analysts.

Original reporting
Published Oct 8, 2026, 10:20 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 8, 2026, 10:31 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Houlihan Lokey, Inc. Stock 12‑Month Price Target Cut to $152.62, Implies 22% Upside — source image
Decision brief

The 30-second read

$HLINeutralLow
01

Why it matters

Analyst consensus remains a Buy, but the lower target may temper short‑term buying pressure.

02

Market read

A modest analyst price‑target revision with limited immediate trading impact.

03

What to watch

Potential upcoming earnings or deal flow could quickly change sentiment.

Relevance 6/10Novelty 6/10Timing: today

Background

Houlihan Lokey is a U.S. investment bank; price‑target changes reflect analyst outlook adjustments.

Company-level read

Ticker impact

$HLINeutralMedium confidence
Context

Analysts cut Houlihan Lokey's average 12‑month price target to $152.62, implying ~22% upside.

Expected impact

potential upward pressure as traders price in the implied upside.

Evidence & confidence

A price‑target cut is new information but the magnitude is modest; market reaction is likely limited.

Market effects

Minor impact on the investment banking sector as analysts adjust expectations.

Limited to U.S. equities; no broader regional effect.

Low global relevance.

Counterpoint

The target cut may be overly cautious; the stock could still rally on broader market optimism.

Key entities

  • Houlihan Lokey, Inc.

    U.S. investment banking firm.

Related articles

$HLIMed

Houlihan Lokey (HLI) Stock Is Up, What You Need To Know

Houlihan Lokey (HLI) shares rose 4.1% after Citizens upgraded the stock to Outperform with a $175 target, citing strong backlog and new business records. The firm's shares cooled to $130.07, up 3.6%. HLI is down 26.2% YTD, trading 35.7% below its 52-week high. Citizens noted improving outlook in financial restructuring and advisory services.

$PIPRMedAI 8/10

A Look Back at Investment Banking & Brokerage Stocks’ Q2 Earnings: Piper Sandler (NYSE:PIPR) Vs The Rest Of The Pack

Investment banking & brokerage stocks reported Q2 earnings, with Piper Sandler (PIPR) revenues up 21.2% YoY, beating estimates. Perella Weinberg (PWP) revenues flat but beat estimates, while Houlihan Lokey (HLI) revenues down 15.6% YoY, missing estimates. LPL Financial (LPLA) revenues up 35.2% YoY, beating estimates. Stifel (SF) revenues up 13.2% YoY, beating estimates. Sector revenues beat consensus by 4.5%, with guidance 1.1% below.

$PJTMed

Investment Banking & Brokerage Stocks Q2 In Review: PJT (NYSE:PJT) Vs Peers

Perella Weinberg (PJT) reported flat revenue of $156.5M, beating EPS estimates, with stock up 7.1%. Houlihan Lokey (HLI) saw revenue drop 15.6% to $511M, missing estimates, with stock down 8%. Goldman Sachs (GS) reported $20.34B revenue, up 39.5%, beating estimates, but stock down 4%. Moelis (MC) reported $409.4M revenue, up 12%, beating estimates, with stock up 2.5%.

$HLIMed

Houlihan Lokey (HLI) Q1 2027 Earnings Call Transcript

Houlihan Lokey (HLI) reported Q1 fiscal 2027 revenues of $511 million and adjusted EPS of $1.35. Financial and Valuation Advisory revenues rose 13% to $89 million, while Corporate Finance revenues fell 24% to $303 million and Financial Restructuring revenues were $119 million. Management cited delayed corporate finance deal timelines amid macro headwinds and expects FY adjusted tax rate of 26% to 28%.